Home

Omega Fund V GP, L.P.

CIK 1641355 · last filed 2022-04-07

Omega Fund V GP, L.P. is a corporate insider who has filed 13 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing shows the insider sold $42.0M of NUVB.WS on Apr 7, 2022. Across all open-market trades the lifetime net is −$128.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $987.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$987.8K

Companies

3

Total Filings

13

Lifetime Open-Market Net

-$128.64M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Nuvation Bio Inc. (NUVB.WS) Delisted 10%+ Owner 20,457,340 $0.01 $104.3K -$83.16M 3 2022-04-07
Morphic Holding, Inc. (MORF) Delisted Director 2,071,768 $56.99 $118.07M -$43.63M 9 2021-05-03
GOSS 10%+ Owner 6,932,012 $0.14 $987.8K -$1.85M 1 2019-09-09

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-04-07 Nuvation Bio Inc. (NUVB.WS) Delisted Sell (S) −7,500,000 -$42.00M EDGAR
2021-12-09 Nuvation Bio Inc. (NUVB.WS) Delisted Sell (S) −4,200,000 -$41.16M EDGAR
2021-05-03 Morphic Holding, Inc. (MORF) Delisted Sell (S) −68,632 -$3.75M EDGAR
2021-04-27 Morphic Holding, Inc. (MORF) Delisted Sell (S) −55,272 -$3.10M EDGAR
2021-04-15 Morphic Holding, Inc. (MORF) Delisted Sell (S) −83,744 -$4.81M EDGAR
2021-04-13 Morphic Holding, Inc. (MORF) Delisted Sell (S) −99,248 -$5.76M EDGAR
2021-04-02 Morphic Holding, Inc. (MORF) Delisted Sell (S) −121,620 -$7.78M EDGAR
2021-03-29 Morphic Holding, Inc. (MORF) Delisted Sell (S) −191,748 -$11.25M EDGAR
2021-02-12 Nuvation Bio Inc. (NUVB.WS) Delisted Mixed +60,410,679 $35.00M EDGAR
2021-01-29 Morphic Holding, Inc. (MORF) Delisted Sell (S) −82,944 -$2.72M EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.